Coronary interventions

DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial

EuroIntervention 2015;11:868-876. DOI: 10.4244/EIJV11I8A177

Jacques Berland
Jacques Berland1*, MD; Thierry Lefèvre2, MD, FESC, FSCAI; Philippe Brenot3, MD; Jean Fajadet4, MD; Pascal Motreff5, MD, PhD; Patrice Guerin6, MD, PhD; Patrick Dupouy7, MD; Christian Schandrin8, MD; DEBSIDE trial investigators
1. Clinique Saint-Hilaire, Rouen, France; 2. Institut Hospitalier Jacques Cartier, Massy, France; 3. Centre Cardiologique d’Evecquemont, Evecquemont, France; 4. Clinique Pasteur, Toulouse, France; 5. Hôpital Gabriel Montpied, Clermont-Ferrand, France; 6.

Aims: We aimed to evaluate the role of drug-eluting balloon SB inflation, using the novel DANUBIO balloon, after placement of a drug-eluting stent in the main branch in patients with bifu

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bifurcation lesiondrug-eluting balloonside branch
Read next article
Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

Latest news